National Institute of Environmental Health Sciences (NIEHS)   Report issue

Government Phase 1 Phase 2 Phase 3
Founded: Bethesda MD United States (1966)

Organization Overview

First Clinical Trial
1994
NCT00342849
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

National Institute of Environmental Health Sciences (NIEHS)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Calcinosis (Phase 2)

Carcinogenesis (Phase 2)

Dermatomyositis (Phase 2)

Inflammation (Phase 2)

Lung Diseases (Phase 2)

Lung Diseases, Obstructive (Phase 2)

Muscular Diseases (Phase 2)

Myositis (Phase 2)

Polymyositis (Phase 2)

Pulmonary Disease, Chronic Obstructive (Phase 2)

Respiratory Aspiration (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 33
  • # of Trial APIs: 23